Message Testing for CKD

February 9, 2023 updated by: University of Pennsylvania

The Impact on Nudges of CKD Testing

Members of CVS/Aetna will receive one of two text messages or receive no text message at all. In the available for members condition, participants will receive a text message that says, "Two common kidney tests have been made available for members. By taking them, you could stay ahead of any problems and keep enjoying life. Schedule a doctor visit today to ask about them." In the Checked Health condition, the message will say, "Have you checked your kidney health recently? By taking two common kidney tests, members can stay ahead of any problems and keep enjoying life. Schedule a doctor visit today to ask about them." There will also be a group of members that do not receive a text message at all.

Study Overview

Detailed Description

The investigators will examine the proportion of participants that book an appointment, proportion of new diagnoses for CKD, creatinine tests and/or albuminuria tests, proportion of participants that looked for more information after receiving the text message. The investigators will examine these metrics 6 months after all of the text messages have gone out ~8,637. The investigators will examine difference in conditions between the metrics listed above in the DV section. The investigators will compare the two conditions to each other, as well as to the group who does not receive a text message. The investigators will conduct a series of chi square tests/logistic regressions to examine the differences.

Study Type

Interventional

Enrollment (Actual)

8637

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Center for Health Incentives and Behavioral Economics (CHIBE)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participant must be a health insurance customer with the company we are working with.
  • All other eligibility criteria are determined by the company and not disclosed to us. They will pick a sample of customers for the study, with participants then being randomly assigned to treatments they qualify for.

Exclusion Criteria:

  • NA

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Available for Members-Text
Participants will receive a text message that says, "Two common kidney tests have been made available for members. By taking them, you could stay ahead of any problems and keep enjoying life. Schedule a doctor visit today to ask about them.
The investigators will examine the impact of different messages on different dimensions of testing for CKD
EXPERIMENTAL: Checked Health-Text
Participants will receive a text message that will say, "Have you checked your kidney health recently? By taking two common kidney tests, members can stay ahead of any problems and keep enjoying life. Schedule a doctor visit today to ask about them."
The investigators will examine the impact of different messages on different dimensions of testing for CKD
EXPERIMENTAL: No Text Message
Participants in this group will not receive a text message at all
The investigators will examine the impact of different messages on different dimensions of testing for CKD

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of appointments
Time Frame: The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
The investigators will examine the proportion of appointments participants make between conditions
The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
Proportion of new diagnoses for CKD, creatinine tests and/or albuminuria tests
Time Frame: The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
Proportion of participants that looked for more information
Time Frame: The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
Participants can request for more information upon receiving the text message
The investigators will examine this 6 months after all of the text messages are sent out~8637 of them

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marissa Sharif, PhD, University of Pennsylvania

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 15, 2022

Primary Completion (ACTUAL)

September 15, 2022

Study Completion (ACTUAL)

December 15, 2022

Study Registration Dates

First Submitted

April 24, 2022

First Submitted That Met QC Criteria

July 15, 2022

First Posted (ACTUAL)

July 18, 2022

Study Record Updates

Last Update Posted (ACTUAL)

February 13, 2023

Last Update Submitted That Met QC Criteria

February 9, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 850936

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The company we are working with will be analyzing the data and informing us of the results. We will not have data to share.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Available for Members Text Message

Clinical Trials on Impact of Nudges on CKD Testing

Subscribe